Osimertinib has emerged as a innovative method in the field of cancerology, especially for patients with advanced non-small cell lung cancer (non-small cell lung cancer).A focused therapy, osimertinib, has shown impressive effectiveness in reducing tumors and lengthening life expectancy.This document explores the reasons behind the significance of first-line treatment with osimertinib, delving into its mode of operation, advantages, and problems faced by medical practitioners.The first-line treatment with osimertinib affects the ErbB (epidermal growth factor receptor) mutation commonly found in non-small cell lung cancer patients.Osimertinib prevents the ErbB TK, thereby preventing…
